drugset / Trial / NCT01770483
The Role Of Nitazoxanide, Interferon Alfa And Ribavirin In Treatment Of Hepatitis C Infected Type 2 Diabetic Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate if nitazoxanide used in combination with interferon alfa and ribavirin is effective in treating Hepatitis c infected type 2 Diabetic patients by improving their sustained viral response by more than 80%.Considering that the study is being conducted in a third world country like Pakistan, the standard treatment of hepatitis C is not cost effective. The aim is to introduce a new treatment comparable in efficacy to peginterferon and also cost effective.
Timeline
- Start
- 2011-07
- Primary completion
- 2013-03
- Completion
- 2013-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nitazoxanide | Other / unclassified | 500 mg | — |
| Background | Ribavirin | Small molecule | 400 mg | — |
| Background | Ribavirin | Small molecule | 1200 mg | — |
| Background | conventional interferon alfa | Unknown | 3e+06 iu | — |